HSA Product

APO-NORTRIPTYLINE CAPSULE 25 mg

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

APO-NORTRIPTYLINE CAPSULE 25 mg

Dosage Form

CAPSULE

Regulatory Information

Approval Number

SIN09253P

Approval Date

March 18, 1997

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 4, 2025

ATC Business ID

XN06AA10

Company Information

ManufacturerAPOTEX INC

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Active Ingredients

NORTRIPTYLINE HCl

Strength: 25 mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy